When we combine these facts with the previously mentioned incidence of NTRK1–3 gene fusions in lung carcinoma, it is more than possible that a certain proportion of samples harboring NTRK fusions (especially NTRK3) are being missed using IHC as a screening method. Here, NTRK1 is linked to lung carcinoma.